DUPHAT 2026 to Highlight Dubai’s Growing Role in Global Pharmaceuticals
DUPHAT 2026 will bring 25,000 visitors and 1,100 brands to Dubai, highlighting…
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development…
Biotech Collaboration Aims to Advance Personalized Brain Cancer Therapy in Saudi Arabia
Northwest Biotherapeutics and SPIMACO have signed an MoU to explore the approval,…
Hikma Reports Strong H1 2026 Results, Reaffirms Full-Year Outlook
Hikma Pharmaceuticals reported 4% revenue growth to $1.728 billion in H1 2026,…
Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
Collaboration to Advance Healthcare Research and Workforce Development
A strategic MoU has been signed to strengthen the UAE pharmaceutical sector…
Abu Dhabi Health Authority and PHRMAG Unite to Boost Oncology and Rare Disease Access
Ma'an and PHRMAG have partnered to improve access to oncology and rare…
Global Oncology Pipeline Set to Expand With Next-Generation Cancer Drug Innovation
Novartis will acquire UK-based Myricx Bio in a deal worth up to…
ADAP Crisis Task Force Strikes Deal to Widen Access to New HIV Pill
Merck has partnered with the ADAP Crisis Task Force to expand access…
New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
IFPMA urged continued global commitment to ending AIDS as a public health…
